{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T00:23:56Z","timestamp":1715473436846},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,10]]},"DOI":"10.7759\/cureus.60069","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T04:32:25Z","timestamp":1715401945000},"source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Risk Factors for Death in the Coronavirus Disease 2019 (COVID-19) Population: Data Analysis from a Large General Hospital in Anhui, China"],"prefix":"10.7759","author":[{"given":"Shi","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Xiaqin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Liwei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Fasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Pingping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Furong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14496","article-title":"Epidemiological and clinical characteristics of 3334 cases with prediagnosis coronavirus disease - 2019 (COVID-19) in Turkey","volume":"75","author":"Simsek Yurt N","year":"2021","unstructured":"Simsek Yurt N, Ocak M, Yurt YC. Epidemiological and clinical characteristics of 3334 cases with prediagnosis coronavirus disease - 2019 (COVID-19) in Turkey. Int J Clin Pract. 2021, 75:e14496. 10.1111\/ijcp.14496","journal-title":"Int J Clin Pract"},{"key":"ref2","unstructured":"Coronavirus disease (COVID-19) epidemiological updates and monthly operational updates. (2024). Accessed. May 11, 2024: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23604","article-title":"Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection","volume":"35","author":"Lin S","year":"2021","unstructured":"Lin S, Mao W, Zou Q, Lu S, Zheng S. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection. J Clin Lab Anal. 2021, 35:e23604. 10.1002\/jcla.23604","journal-title":"J Clin Lab Anal"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson EJ","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, et al.. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020, 584:430-6. 10.1038\/s41586-020-2521-4","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30264-3","article-title":"Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study","volume":"8","author":"Clark A","year":"2020","unstructured":"Clark A, Jit M, Warren-Gash C, et al.. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020, 8:e1003-17. 10.1016\/S2214-109X(20)30264-3","journal-title":"Lancet Glob Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu N","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020, 382:727-33. 10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses","year":"2020","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020, 5:536-44. 10.1038\/s41564-020-0695-z","journal-title":"Nat Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2020.07.034","article-title":"Benefits and limitations of serological assays in COVID-19 infection","volume":"67","author":"Sidiq Z","year":"2020","unstructured":"Sidiq Z, Hanif M, Dwivedi KK, Chopra KK. Benefits and limitations of serological assays in COVID-19 infection. Indian J Tuberc. 2020, 67:S163-6. 10.1016\/j.ijtb.2020.07.034","journal-title":"Indian J Tuberc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry BM","year":"2020","unstructured":"Henry BM, de Oliveira MH, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020, 58:1021-8. 10.1515\/cclm-2020-0369","journal-title":"Clin Chem Lab Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082489","article-title":"Venous thromboembolism among hospitalized patients with COVID-19 undergoing thromboprophylaxis: a systematic review and meta-analysis","volume":"9","author":"Chi G","year":"2020","unstructured":"Chi G, Lee JJ, Jamil A, et al.. Venous thromboembolism among hospitalized patients with COVID-19 undergoing thromboprophylaxis: a systematic review and meta-analysis. J Clin Med. 2020, 9:2489. 10.3390\/jcm9082489","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.67.Suppl1.20200917","article-title":"The role of serum inflammatory markers, albumin, and hemoglobin in predicting the diagnosis in patients admitted to the emergency department with a pre-diagnosis of COVID-19","volume":"14","author":"Akman C","year":"2020","unstructured":"Akman C, Bak\u0131rd\u00f6\u011fen S. The role of serum inflammatory markers, albumin, and hemoglobin in predicting the diagnosis in patients admitted to the emergency department with a pre-diagnosis of COVID-19. Rev Assoc Med Bras (1992). 2020, 14:1037-41. 10.1590\/1806-9282.67.Suppl1.20200917","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2020.8142","article-title":"Is albumin predictor of mortality in COVID-19?","volume":"35","author":"Violi F","year":"2021","unstructured":"Violi F, Cangemi R, Romiti GF, et al.. Is albumin predictor of mortality in COVID-19?. Antioxid Redox Signal. 2021, 35:139-42. 10.1089\/ars.2020.8142","journal-title":"Antioxid Redox Signal"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai CC","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020, 55:105924. 10.1016\/j.ijantimicag.2020.105924","journal-title":"Int J Antimicrob Agents"},{"key":"ref14","article-title":"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19","volume":"76","author":"Zhang JJ","year":"2021","unstructured":"Zhang JJ, Cao YY, Tan G, et al.. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. Allergy. 2021, 76:533-50.","journal-title":"Allergy"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1017\/S095026882000179X","article-title":"Risk factors of severe cases with COVID-19: a meta-analysis","volume":"148","author":"Ou M","year":"2020","unstructured":"Ou M, Zhu J, Ji P, et al.. Risk factors of severe cases with COVID-19: a meta-analysis. Epidemiol Infect. 2020, 148:e175. 10.1017\/S095026882000179X","journal-title":"Epidemiol Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin C","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, et al.. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020, 71:762-8. 10.1093\/cid\/ciaa248","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23467","article-title":"Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19","volume":"34","author":"Chen X","year":"2020","unstructured":"Chen X, Yan L, Fei Y, Zhang C. Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19. J Clin Lab Anal. 2020, 34:e23467. 10.1002\/jcla.23467","journal-title":"J Clin Lab Anal"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211048808","article-title":"Significance of MPV, RDW and PDW with the severity and mortality of COVID-19 and effects of acetylsalicylic acid use","volume":"27","author":"Ayd\u0131ny\u0131lmaz F","year":"2021","unstructured":"Ayd\u0131ny\u0131lmaz F, Aksakal E, Pamukcu HE, et al.. Significance of MPV, RDW and PDW with the severity and mortality of COVID-19 and effects of acetylsalicylic acid use. Clin Appl Thromb Hemost. 2021, 27:10.1177\/10760296211048808","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58050613","article-title":"Diagnostic accuracy of the RDW for predicting death in COVID-19","volume":"58","author":"Guan\u00ed-Guerra E","year":"2022","unstructured":"Guan\u00ed-Guerra E, Torres-Murillo B, Mu\u00f1oz-Corona C, Rodr\u00edguez-Jim\u00e9nez JC, Mac\u00edas AE, Scavo-Montes DA, Alvarez JA. Diagnostic accuracy of the RDW for predicting death in COVID-19. Medicina (Kaunas). 2022, 58:613. 10.3390\/medicina58050613","journal-title":"Medicina (Kaunas)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/all.14496","article-title":"Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients","volume":"76","author":"Zhang JJ","year":"2021","unstructured":"Zhang JJ, Cao YY, Tan G, et al.. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy. 2021, 76:533-50. 10.1111\/all.14496","journal-title":"Allergy"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/all.14452","article-title":"Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status","volume":"76","author":"Du H","year":"2021","unstructured":"Du H, Dong X, Zhang JJ, et al.. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy. 2021, 76:510-32. 10.1111\/all.14452","journal-title":"Allergy"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3201\/eid2608.201160","article-title":"Prognostic value of leukocytosis and lymphopenia for coronavirus disease severity","volume":"26","author":"Huang G","year":"2020","unstructured":"Huang G, Kovalic AJ, Graber CJ. Prognostic value of leukocytosis and lymphopenia for coronavirus disease severity. Emerg Infect Dis. 2020, 26:1839-41. 10.3201\/eid2608.201160","journal-title":"Emerg Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007335","article-title":"COVID-19 coagulopathy, thrombosis, and bleeding","volume":"136","author":"Chan NC","year":"2020","unstructured":"Chan NC, Weitz JI. COVID-19 coagulopathy, thrombosis, and bleeding. Blood. 2020, 136:381-3. 10.1182\/blood.2020007335","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6159720","article-title":"D-dimer and prothrombin time are the significant indicators of severe Covid-19 and poor prognosis","volume":"2020","author":"Long H","year":"2020","unstructured":"Long H, Nie L, Xiang X, et al.. D-dimer and prothrombin time are the significant indicators of severe Covid-19 and poor prognosis. Biomed Res Int. 2020, 2020:10.1155\/2020\/6159720","journal-title":"Biomed Res Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.06.016","article-title":"Pulmonary thrombosis and thromboembolism in COVID-19","volume":"160","author":"Poor HD","year":"2021","unstructured":"Poor HD. Pulmonary thrombosis and thromboembolism in COVID-19. Chest. 2021, 160:1471-80. 10.1016\/j.chest.2021.06.016","journal-title":"Chest"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00217-0","article-title":"A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)","volume":"8","author":"Danwang C","year":"2020","unstructured":"Danwang C, Endomba FT, Nkeck JR, Wouna DL, Robert A, Noubiap JJ. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res. 2020, 8:37. 10.1186\/s40364-020-00217-0","journal-title":"Biomark Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31301","article-title":"Longitudinal association between markers of liver injury and mortality in COVID-19 in China","volume":"72","author":"Lei F","year":"2020","unstructured":"Lei F, Liu YM, Zhou F, et al.. Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology. 2020, 72:389-98. 10.1002\/hep.31301","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30084-4","article-title":"COVID-19 and the liver: little cause for concern","volume":"5","author":"Bangash MN","year":"2020","unstructured":"Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020, 5:529-30. 10.1016\/S2468-1253(20)30084-4","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11122344","article-title":"Clinical usefulness of red cell distribution width\/albumin ratio to discriminate 28-day mortality in critically ill patients with pneumonia receiving invasive mechanical ventilation, compared with lacate\/albumin ratio: a retrospective cohort study","volume":"11","author":"Jeong JH","year":"2021","unstructured":"Jeong JH, Heo M, Lee SJ, Jeong YY, Lee JD, Yoo JW. Clinical usefulness of red cell distribution width\/albumin ratio to discriminate 28-day mortality in critically ill patients with pneumonia receiving invasive mechanical ventilation, compared with lacate\/albumin ratio: a retrospective cohort study. Diagnostics (Basel). 2021, 11:2344. 10.3390\/diagnostics11122344","journal-title":"Diagnostics (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S328035","article-title":"Association between red blood cell distribution width-to-albumin ratio and prognosis of patients with aortic aneurysms","volume":"14","author":"Long J","year":"2021","unstructured":"Long J, Xie X, Xu D, et al.. Association between red blood cell distribution width-to-albumin ratio and prognosis of patients with aortic aneurysms. Int J Gen Med. 2021, 14:6287-94. 10.2147\/IJGM.S328035","journal-title":"Int J Gen Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24351","article-title":"Association between red blood cell distribution width-to-albumin ratio and diabetic retinopathy","volume":"36","author":"Zhao F","year":"2022","unstructured":"Zhao F, Liu M, Kong L. Association between red blood cell distribution width-to-albumin ratio and diabetic retinopathy. J Clin Lab Anal. 2022, 36:e24351. 10.1002\/jcla.24351","journal-title":"J Clin Lab Anal"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa578","article-title":"Postmortem findings in Italian patients with COVID-19: a descriptive full autopsy study of cases with and without comorbidities","volume":"222","author":"Falasca L","year":"2020","unstructured":"Falasca L, Nardacci R, Colombo D, et al.. Postmortem findings in Italian patients with COVID-19: a descriptive full autopsy study of cases with and without comorbidities. J Infect Dis. 2020, 222:1807-15. 10.1093\/infdis\/jiaa578","journal-title":"J Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.07.030","article-title":"Outcomes of patients with end-stage kidney disease hospitalized with COVID-19","volume":"98","author":"Ng JH","year":"2020","unstructured":"Ng JH, Hirsch JS, Wanchoo R, et al.. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020, 98:1530-9. 10.1016\/j.kint.2020.07.030","journal-title":"Kidney Int"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00452-0","article-title":"Pathophysiology of COVID-19-associated acute kidney injury","volume":"17","author":"Legrand M","year":"2021","unstructured":"Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, Cantaluppi V. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021, 17:751-64. 10.1038\/s41581-021-00452-0","journal-title":"Nat Rev Nephrol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04560421","article-title":"Evidence for and against direct kidney infection by SARS-CoV-2 in patients with COVID-19","volume":"16","author":"Hassler L","year":"2021","unstructured":"Hassler L, Reyes F, Sparks MA, Welling P, Batlle D. Evidence for and against direct kidney infection by SARS-CoV-2 in patients with COVID-19. Clin J Am Soc Nephrol. 2021, 16:1755-65. 10.2215\/CJN.04560421","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236240","article-title":"Pre-existing traits associated with Covid-19 illness severity","volume":"15","author":"Ebinger JE","year":"2020","unstructured":"Ebinger JE, Achamallah N, Ji H, et al.. Pre-existing traits associated with Covid-19 illness severity. PLoS One. 2020, 15:10.1371\/journal.pone.0236240","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01509-1","article-title":"Risk factors for Covid-19 severity and fatality: a structured literature review","volume":"49","author":"Wolff D","year":"2021","unstructured":"Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021, 49:15-28. 10.1007\/s15010-020-01509-1","journal-title":"Infection"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.04.012","article-title":"Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China","volume":"26","author":"Zhang J","year":"2020","unstructured":"Zhang J, Wang X, Jia X, et al.. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020, 26:767-72. 10.1016\/j.cmi.2020.04.012","journal-title":"Clin Microbiol Infect"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/190764-analysis-of-risk-factors-for-death-in-the-coronavirus-disease-2019-covid-19-population-data-analysis-from-a-large-general-hospital-in-anhui-china","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T04:32:31Z","timestamp":1715401951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/190764-analysis-of-risk-factors-for-death-in-the-coronavirus-disease-2019-covid-19-population-data-analysis-from-a-large-general-hospital-in-anhui-china"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.60069","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,10]]}}}